DuPont Launches AmberLite FPA57 Resin for Acid Purification

29.01.26 13:01 Uhr

Werte in diesem Artikel
Aktien

37,22 EUR 0,16 EUR 0,43%

Indizes

6.913,4 PKT -64,6 PKT -0,93%

DuPont de Nemours, Inc. DD has launched DuPont AmberLite FPA57 resin, a next-generation weak base anion exchange resin aimed at improving efficiency in organic acid purification.  The new resin offers 5–10% longer cycle times compared to current options, along with higher exchange capacity and improved fouling resistance, enabling producers of acids like lactic and citric acid to extend run lengths and maintain consistent product quality.  Designed as a seamless upgrade to AmberLite FPA55, it retains the same particle size and flow characteristics, allowing easy adoption without system modifications. Additionally, the resin helps reduce regenerant chemical use and wastewater generation, driving more cost-efficient operations across the food, beverage, pharmaceutical and biodegradable plastics industries.  DuPont emphasizes that the FPA57 resin can also improve overall yield and operational reliability, supporting manufacturers in scaling production efficiently. With this launch, DuPont continues to reinforce its leadership in innovative ion exchange solutions for industrial purification processes. Shares of DD are down 41.7% in the past year compared with the industry’s 20.8% decline. Image Source: Zacks Investment ResearchDD’s Zacks Rank & Key PicksDD currently carries a Zacks Rank of #4 (Sell).Some better-ranked stocks in the Basic Materials space are Albemarle Corporation ALB, LSB Industries LXU, and Methanex Corporation MEOH. ALB and LXU carry a Zacks Rank of #1 (Strong Buy), while MEOH has a Zacks Rank of #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for ALB’s current fiscal-year loss stands at $1 per share, implying a 57.3% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once, with an average surprise of 35.3%. Shares of ALB have gained 113.6% over the past year.The Zacks Consensus Estimate for LXU’s current fiscal-year earnings is pegged at 36 cents per share, indicating a 57% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing twice, with an average surprise of 141.3%. Shares of LXU are up 9.9% over the past year.The Zacks Consensus Estimate for MEOH’s current fiscal-year earnings is pegged at $3.17 per share. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once, with an average surprise of 17.4%. Shares of MEOH have fell 4.1% over the past year.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.SeeWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Methanex Corporation (MEOH): Free Stock Analysis Report Albemarle Corporation (ALB): Free Stock Analysis Report Lsb Industries Inc. (LXU): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: DuPont de Nemours und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf DuPont de Nemours

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DuPont de Nemours

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu DuPont de Nemours

Wer­bung

Analysen zu DuPont de Nemours

DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
10.06.2019DowDuPont OutperformCowen and Company, LLC
06.02.2019DowDuPont Market PerformCowen and Company, LLC
DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
10.06.2019DowDuPont OutperformCowen and Company, LLC
12.10.2018DowDuPont buyDeutsche Bank AG
29.03.2018DowDuPont OutperformBMO Capital Markets
DatumRatingAnalyst
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
06.02.2019DowDuPont Market PerformCowen and Company, LLC
12.09.2017DowDuPont NeutralMonness, Crespi, Hardt & Co.
31.05.2017Dow Chemical Market PerformCowen and Company, LLC
26.04.2017DuPont (E I DuPont de Nemours and Sector PerformRBC Capital Markets
DatumRatingAnalyst
05.01.2009Dow Chemical verkaufenEuro am Sonntag
11.04.2007Dow Chemical verkaufenHamburger Sparkasse
03.02.2006Update Rohm and Haas Co.: ReduceUBS
07.07.2005Update Rohm and Haas Co.: SellLongbow

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DuPont de Nemours nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen